Skip to content
Unrated Drug recall · FDA · Published March 24, 2014

Apotex PAXIL CR 25mg Tablets Recall: Chemical Contamination Risk

Apotex recalls PAXIL CR 25mg tablets due to chemical contamination from residual materials. Affected lots may contain unsafe solvents. Stop using immediately if you have the recalled product.

🇺🇸 FDA recall #D-1578-2014DrugApotex ›
Take action

Contact the company

Recalling firmApotex Inc.150 Signet Drive · Toronto, Canada
✎ GovInfoNow plain-language explainer

Apotex is recalling PAXIL CR 25mg controlled-release tablets because they were made with contaminated ingredients that could be harmful. This affects people who have the specific lot number and expiration date listed in the recall. Read more at govinfonow.com/recall/46183-apotex-paxil-cr-25mg-tablets-recall-chemical-contamination-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/46183-apotex-paxil-cr-25mg-tablets-recall-chemical-contamination-risk · Updated August 20, 2026 · FDA enforcement record: FDA #D-1578-2014

Cite this page

“Apotex PAXIL CR 25mg Tablets Recall: Chemical Contamination Risk.” GovInfoNow, updated August 20, 2026. https://govinfonow.com/recall/46183-apotex-paxil-cr-25mg-tablets-recall-chemical-contamination-risk. Based on FDA recall #D-1578-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1578-2014%22&limit=1).

The FDA announced on March 24, 2014, that Apotex Inc. voluntarily recalled PAXIL CR (Paroxetine HCL) Controlled-Release Tablets 25 mg due to chemical contamination from residual materials and solvents in the active pharmaceutical ingredient batches.

How to tell if you have it

  • Brand: Apotex
  • Product: PAXIL CR (Paroxetine HCL) Controlled-Release Tablets 25 mg, 30-count bottle
  • NDC: 60505-3669-3
  • Lot #: 2F004
  • Expiration Date: 06/15
  • Manufacturer: GlaxoSmithKline, RTP, NC 27709
  • Distributed nationwide and in Puerto Rico

The hazard

The product was manufactured with active pharmaceutical ingredient batches contaminated with residual materials and solvents. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show Apotex Inc. has had 19 other recalls on record since April 30, 2012. Other recent recalls of similar products include Apotex Metformin Tablets Recall regarding NDMA impurity risk (May 27, 2020), Apotex Atorvastatin 40mg Tablets Recall for foreign pravastatin presence (Oct. 22, 2019), and Apotex Rite Aid Maximum Strength Ranitidine Tablets Recall for possible NDMA contamination (Sept. 24, 2019). Additional recent recalls include Apotex Paxil CR 37.5mg Tablets Recall for failed stability testing (Aug. 13, 2026), Apotex Recalls Paroxetine 37.5mg due to dissolution failure (Sept. 23, 2026), and Apotex Desmopressin Nasal Spray Recall for defective bottle caps risk (April 8, 2026).

How to tell if you have this one

Check for the product name 'PAXIL CR (Paroxetine HCL) Controlled-Release Tablets 25 mg, 30-count bottle', manufactured by GlaxoSmithKline, lot #2F004, and expiration date 06/15.

  • Brand
    Apotex
  • Category
    Drug
FDA recall event · 9 products

All 9 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    Nationwide and Puerto Rico
Recall numberProduct, codes & lotsQuantityNDC
D-1574-2014Paroxetine HCL Controlled-Release Tablets 12.5 mg, 30-count bottle, Rx only, Manufactured by GlaxoSmithKline, RTP, NC 27709, Manufactured for Apotex Corp., Weston, FL 33328, NDC 60505-3673-3; Lot # 2A001, Exp. 01/15 Lot # 2A002, Exp. 01/15 Lot # 2C003, Exp. 03/15 Lot # 2F005, Exp. 06/15 Lot # 2G006, Exp. 07/15—60505-1316-3, 60505-1317-3, 60505-1318-3, 60505-3673-3, 60505-3674-3, 60505-3675-3
D-1575-2014PAXIL (Paroxetine HCL) Oral Suspension 10 mg/5 mL - 250 mL bottle, Rx Only, Manufactured by GlaxoSmithKline, RTP, NC 27709. Distributed by Apotex Corp., Westin, FL 33326, NDC 60505-0402-5; Lot # 2A001, Exp. 01/15; Lot # 2C002, Exp. 03/1513,429 bottles—
D-1576-2014Paroxetine HCL Controlled-Release Tablets 25 mg, 30-count bottle, Rx only, Manufactured by GlaxoSmithKline, RTP, NC 27709, Manufactured for Apotex Corp., Weston, FL 33328, NDC 60505-3674-3; Lot # 2A002, Exp. 01/15 Lot # 2A003, Exp. 01/15 Lot # 2C004, Exp. 03/15 Lot # 2C005, Exp. 03/15 Lot # 2E008, Exp. 05/15 Lot # 2F009, Exp. 06/15 Lot # 2F010, Exp. 06/15 Lot # 2H011, Exp. 08/15 Lot # 2H012, Exp. 08/15 Lot # 2H013, Exp. 0815—60505-1316-3, 60505-1317-3, 60505-1318-3, 60505-3673-3, 60505-3674-3, 60505-3675-3
D-1577-2014Paroxetine HCL Controlled-Release Tablets 37.5 mg, 30-count bottle, Rx only, Manufactured by GlaxoSmithKline, RTP, NC 27709, Manufactured for Apotex Corp., Weston, FL 33328, NDC 60505-3675-3; Lot # 2C002, Exp. 03/15 Lot # 2H004, Exp. 08/15 Lot # 2H006, Exp. 08/15—60505-1316-3, 60505-1317-3, 60505-1318-3, 60505-3673-3, 60505-3674-3, 60505-3675-3
D-1578-2014PAXIL CR (Paroxetine HCL) Controlled-Release Tablets 25 mg, 30-count bottle, Rx only, Manufactured by GlaxoSmithKline, RTP, NC 27709, Manufactured for Apotex Corp., Weston, FL 33328, NDC 60505-3669-3; Lot # 2F004, Exp. 06/15—60505-4377-3, 60505-4378-3, 60505-4379-3, 60505-3668-3, 60505-3669-3, 60505-3670-3
D-1579-2014PAXIL CR (Paroxetine HCL) Controlled-Release Tablets 37.5 mg, 30-count bottle, Rx only, Manufactured by GlaxoSmithKline, RTP, NC 27709, Manufactured for Apotex Corp., Weston, FL 33328, NDC 60505-3670-3; Lot # 2E001; Exp. 05/15—60505-4377-3, 60505-4378-3, 60505-4379-3, 60505-3668-3, 60505-3669-3, 60505-3670-3
D-1580-2014PAXIL (Paroxetine HCL) Tablets 10 mg, 30-count bottle, Rx only, Manufactured by GlaxoSmithKline, RTP, NC 27709, Manufactured for Apotex Corp., Weston, FL 33328, NDC 60505-3663-3; Lot # 2ZP7113, Exp. 08/15——
D-1581-2014PAXIL (Paroxetine HCL) Tablets 20 mg, 30-count bottle, Rx only, Manufactured by GlaxoSmithKline, RTP, NC 27709, Manufactured for Apotex Corp., Weston, FL 33328, NDC 60505-3664-3; Lot # 2ZP5499, Exp. 02/15——
D-1582-2014PAXIL (Paroxetine HCL) Tablets 40 mg, 30-count bottle, Rx only, Manufactured by GlaxoSmithKline, RTP, NC 27709, Manufactured for Apotex Corp., Weston, FL 33328, NDC 60505-3666-3; Lot # 2ZP3908, Exp. 05/15——
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for the specific lot number (2F004) and expiration date (06/15) on the product label.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 6 months after the firm started it.

1. Firm started the recall: Mar 24, 201412. FDA classified it Class II: Sep 3, 201423. Published in FDA’s Enforcement Report: Sep 10, 201434. FDA terminated the recall: Sep 23, 201442014
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1578-2014 (March 24, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1578-2014 to see it in context.
  • Plain-language summary written by qwen3:4b on August 20, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA